BURLINGTON – Global life science giant Labcorp has closed its office in Ukraine’s capital city and is monitoring its ongoing operations in Russia on a “case by case basis,” the company said Tuesday.

“Labcorp is closely monitoring the rapidly changing situation in Ukraine and Eastern Europe,” a corporate spokesperson told WRAL TechWire.

“Our top priorities are the safety and wellbeing of our Labcorp employees, the patients enrolled in clinical trials and the continuity of clinical research being conducted in the region.”

Labcorp has more than 70,000 employees spread across some 100 countries worldwide.

Red Hat discontinues operations in Russia, is helping evacuate Ukraine employees

Responding to questions from WRAL TechWire, the spokesperson added more details:

  • What is status of Labcorp operations/employees in Ukraine and Russia?

The safety and wellbeing of our employees in Ukraine and Eastern Europe is our top priority. At this time the office in Kyiv is closed and we are supporting employees to work remotely as they are able.

We have been communicating with our employees in the region to provide information and support, assess their needs and determine their and their family’s safety. At this time, all Labcorp employees are accounted for. We will continue to communicate with and support them through this evolving situation.

  • Does the company plan to suspend operations in Russia?

We are working closely with pharmaceutical and medical device sponsors on a case-by-case basis regarding work in Russia while prioritizing the safety of employees and patients in clinical research.

IBM suspends ‘all business’ in Russia, joins growing exodus of companies